Karen E. Peterson, VP, Regulatory and Quality at ENTELLUS MEDICAL INC (ENTL), sold 650 shares at $20.17 ($13K) on 2017-10-09, disclosed to the SEC on 2017-10-11.
Scheduled sale ($13k) by VP, Regulatory and Quality under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ENTL | SELL | 2017-01-05 | $378K | — | Filing → |
| ENTL | SELL | 2016-03-03 | $80K | — | Filing → |
| ENTL | SELL | 2016-02-11 | $80K | — | Filing → |